TRACETracking with Recency Assays to Control the Epidemic
Tracking with Recency Assays to Control the Epidemic (TRACE)
Disease surveillance to stop HIV transmission in its tracks.
Remarkable progress has been made toward HIV epidemic control in some high-burden countries, but many gaps remain. Identifying people with undiagnosed HIV infection, especially those who have been recently infected, is essential to realize the individual benefit of rapid treatment initiation and to prevent HIV transmission to others. A new rapid HIV test that can distinguish a recent HIV-1 infection (acquired within the last 12 months) from a long-term infection now offers new opportunities to improve the health of people living with HIV and to advance public health efforts toward epidemic control.
With funding from the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC), ICAP at Columbia University is working in collaboration with CDC, ministries of health, and local organizations to roll out rapid HIV recency testing in selected high-burden countries as part of a comprehensive approach to respond to the HIV epidemic.